121 related articles for article (PubMed ID: 11431583)
41. Elevated serum interleukin 1 receptors and interleukin 1B in patients with Behçet's disease: correlations with disease activity and severity.
Yosipovitch G; Shohat B; Bshara J; Wysenbeek A; Weinberger A
Isr J Med Sci; 1995 Jun; 31(6):345-8. PubMed ID: 7607852
[TBL] [Abstract][Full Text] [Related]
42. Behcet's disease and its oral manifestations.
Georgaklis CC
Dent Today; 2004 Jun; 23(6):92-5. PubMed ID: 15218677
[No Abstract] [Full Text] [Related]
43. Activated protein C resistance and its correlation with thrombophlebitis in Behçet's disease.
Kavala M; Namdar ND; Kocatürk E; Türkoğlu Z; Zindanci I
Acta Dermatovenerol Croat; 2011; 19(2):87-90. PubMed ID: 21703154
[TBL] [Abstract][Full Text] [Related]
44. Diagnostic yield of heat shock protein 70 (HSP-70) and anti-HSP-70 in Behcet-induced uveitis.
Sahebari M; Hashemzadeh K; Mahmoudi M; Saremi Z; Mirfeizi Z
Scand J Immunol; 2013 Jun; 77(6):476-81. PubMed ID: 23701436
[TBL] [Abstract][Full Text] [Related]
45. Assessment of QRS duration and presence of fragmented QRS in patients with Behçet's disease.
Sayin MR; Akpinar I; Gursoy YC; Kiran S; Gudul NE; Karabag T; Koca R; Aydin M
Coron Artery Dis; 2013 Aug; 24(5):398-403. PubMed ID: 23612364
[TBL] [Abstract][Full Text] [Related]
46. Plasma homocysteine level in patients with Behcet's disease with or without thrombosis.
Shahram F; Faridar A; Hamedani MG; Nadji A; Naderi N; Mojarad Shafiee N; Rasker JJ; Davatchi F
Arch Iran Med; 2010 Nov; 13(6):476-81. PubMed ID: 21039001
[TBL] [Abstract][Full Text] [Related]
47. Serum-soluble selectin levels in patients with Behçet's disease.
Ateş A; Tiryaki OA; Olmez U; Tutkak H
Clin Rheumatol; 2007 Mar; 26(3):411-7. PubMed ID: 17206396
[TBL] [Abstract][Full Text] [Related]
48. Prolactin and thyroid hormones in patients with systemic sclerosis: correlations with disease manifestations and activity.
Shahin AA; Abdoh S; Abdelrazik M
Z Rheumatol; 2002 Dec; 61(6):703-9. PubMed ID: 12491136
[TBL] [Abstract][Full Text] [Related]
49. [Pulmonary embolism and Behçet's disease].
Hammami S; Addad F; Kaoubaa N; Golli M; Chebbi W; Hamzaoui A; Hammami M; Ben Farhat M; Majhoub S
Arch Mal Coeur Vaiss; 2006 Sep; 99(9):786-90. PubMed ID: 17067096
[TBL] [Abstract][Full Text] [Related]
50. Serum immunoglobulin D levels in patients with Behçet's disease according to different clinical manifestations.
Lucherini OM; Vitale A; Orlando I; Sota J; Fabiani C; Franceschini R; Simpatico A; Frediani B; Galeazzi M; Tosi GM; Cantarini L
Clin Exp Rheumatol; 2018; 36(6 Suppl 115):110-115. PubMed ID: 30582507
[TBL] [Abstract][Full Text] [Related]
51. Pathergy reaction in Behçet's disease: lack of correlation with mucocutaneous manifestations and systemic disease expression.
Krause I; Molad Y; Mitrani M; Weinberger A
Clin Exp Rheumatol; 2000; 18(1):71-4. PubMed ID: 10728447
[TBL] [Abstract][Full Text] [Related]
52. Serum Interleukin-33 in Behcet's Disease: Its Relation to Disease Activity and Clinical Manifestations.
Fawzy RM; Said EA; Mohamed SM; Fouad NA; Akl EM
Egypt J Immunol; 2015 Jun; 22(2):1-8. PubMed ID: 28502139
[TBL] [Abstract][Full Text] [Related]
53. The relationship between serum levels of angiogenin, bFGF, VEGF, and ocular involvement in patients with Behçet's disease.
Yalçındağ A; Gedik-Oğuz Y; Yalçındağ FN
Graefes Arch Clin Exp Ophthalmol; 2013 Jul; 251(7):1807-12. PubMed ID: 23553285
[TBL] [Abstract][Full Text] [Related]
54. Iron deficiency state in resistant oral aphthosis of Behcet's disease.
Dormohammadi Toosi T; Shahram F; Ghodsi SZ; Nadji A; Tehrani Banihashemi A; Larimi SR; Davatchi F
Int J Rheum Dis; 2014 May; 17(4):425-9. PubMed ID: 24848287
[TBL] [Abstract][Full Text] [Related]
55. Evaluation of serum resistin levels in patients with ocular and non-ocular Behçet's disease.
Yalçindag FN; Yalçindag A; Batioglu F; Caglayan O; Kisa U; Ozdemir O
Can J Ophthalmol; 2008 Aug; 43(4):473-5. PubMed ID: 18711464
[TBL] [Abstract][Full Text] [Related]
56. Serum prolactin levels and Behçet disease.
Proença H; Ferreira C; Miranda M; Castanheira-Dinis A; Monteiro-Grillo M
Eur J Ophthalmol; 2007; 17(3):404-7. PubMed ID: 17534824
[TBL] [Abstract][Full Text] [Related]
57. Adenosine deaminase enzyme levels, their relation with disease activity, and the effect of colchicine on adenosine deaminase levels in patients with Behçet's disease.
Calis M; Ates F; Yazici C; Kose K; Kirnap M; Demir M; Borlu M; Evereklioglu C
Rheumatol Int; 2005 Aug; 25(6):452-6. PubMed ID: 15868151
[TBL] [Abstract][Full Text] [Related]
58. Tocilizumab in severe and refractory Behcet's disease: Four cases and literature review.
Deroux A; Chiquet C; Bouillet L
Semin Arthritis Rheum; 2016 Jun; 45(6):733-7. PubMed ID: 26743073
[TBL] [Abstract][Full Text] [Related]
59. Increased serum levels of interleukin-8 in polyarteritis nodosa and Behçet's disease.
Freire Ade L; Bertolo MB; de Pinho AJ; Samara AM; Fernandes SR
Clin Rheumatol; 2004 Jun; 23(3):203-5. PubMed ID: 15168145
[TBL] [Abstract][Full Text] [Related]
60. Increased Serum Antibody Titer against HPV-16 Antigen in Patients with Behçet's Disease.
Kim KY; Kim DY; Seo J; Ahn Y; Kim DS
J Korean Med Sci; 2017 Apr; 32(4):599-604. PubMed ID: 28244285
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
